0001415889-19-000052.txt : 20190114
0001415889-19-000052.hdr.sgml : 20190114
20190114215521
ACCESSION NUMBER: 0001415889-19-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190114
FILED AS OF DATE: 20190114
DATE AS OF CHANGE: 20190114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Singh Shawn
CENTRAL INDEX KEY: 0001412071
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 19526107
MAIL ADDRESS:
STREET 1: C/O VISTAGEN THERAPEUTICS, INC.
STREET 2: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-01142019_090108.xml
X0306
4
2019-01-14
0001411685
VistaGen Therapeutics, Inc.
VTGN
0001412071
Singh Shawn
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
CHIEF EXECUTIVE OFFICER
Stock Option (Right to Buy)
1.70
2019-01-14
4
A
0
220000
1.70
A
2029-01-14
Common Stock
220000
220000
D
25% of the shares subject to the Option reported herein shall vest on the Vesting Start Date of January 14, 2019, and 1/24th of the remaining shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter.
/s/ Jerrold D. Dotson, Attorney-in-Fact
2019-01-14